Drug intelligence / Profile preview

Lidan Zhitong Jiaonang

Development stage: Unknown
Lead developer: Hunan Hansen Pharmaceutical
Administration: Oral

Overview

Lidan Zhitong Jiaonang is a traditional Chinese medicine (TCM) capsule developed and manufactured by Yunnan Yongzitang, a subsidiary of Hunan Hansen Pharmaceutical. The formulation is designed to benefit the gallbladder and relieve pain, primarily indicated for gallbladder-related conditions and associated biliary pain. As a traditional herbal product, it consists of a complex mixture of botanical ingredients and does not have a defined molecular mechanism of action or specific biological targets. It is currently approved and marketed in China as an oral capsule formulation.

Brand names: Lidan Zhitong Jiaonang
Other names: 利胆止痛胶囊Lidan Zhitong CapsulesGallbladder-Benefiting Pain-Relieving Capsule

Beyond the preview

Go deeper on Lidan Zhitong Jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lidan Zhitong Jiaonang.

Explore the full profile